Orexin Receptor Antagonism, a New Sleep‐Enabling Paradigm: A Proof‐of‐Concept Clinical Trial

E-ISSN： 1532-6535|91|6|975-985

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.6, 2012-06, pp. : 975-985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptive Music Therapy for the Treatment of Depression: A Proof-of-Concept Study and Prospective Controlled Clinical Trial of Efficacy

Psychotherapy and Psychosomatics, Vol. 79, Iss. 5, 2010-08 ,pp. : 321-322

Karger

Access to resources Recommend Favorite

Proof‐of‐Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence

ALCOHOLISM (ELECTRONIC), Vol. 40, Iss. 9, 2016-09 ,pp. : 1935-1944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effective Biomarkers for Proof-of-Concept

Current Medical Imaging Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 25-27

Bentham Science Publishers

Access to resources Recommend Favorite

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof‐of‐Concept Trial of Metformin

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3190-3200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof‐of‐Concept from Experimental Studies to Clinical VF

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 10, 2015-10 ,pp. : 1117-1126

John Wiley & Sons Inc

Access to resources Recommend Favorite